Search

everythinglearnresearchcommunity

for

Search:↓

New hormonal contraceptives are safer, have fewer side effects, and offer health benefits for women.

New treatments for male hypogonadism are effective and should be personalized.

The document concludes that early recognition and treatment of PCOS in adolescents is crucial for managing symptoms and long-term health risks.

Hormones and genetics affect hair growth and patterns, with some changes reversible and others not.

The document concludes that for hair and feather growth, it's better to target the environment around stem cells than the cells themselves.

Finasteride may reduce prostate cancer spread by lowering certain enzyme levels.

PCOS symptoms change with age; younger women have higher androgen levels and less metabolic issues, while older women face more metabolic challenges despite milder PCOS symptoms.

The review recommends hormone replacement therapy for women with premature ovarian insufficiency to manage symptoms and protect health, with specific approaches for different groups.

PPAR agonists show promise for skin conditions but need more research before being a main treatment.

The conclusion is that individual differences in COVID-19 severity are influenced by factors like age, sex, race, and genetics, which are important for personalized medicine.

The study found that certain microRNAs are higher in the cells and lower in the fluid of women with a specific type of polycystic ovary syndrome, and one microRNA could potentially help diagnose the condition.

Chemotherapy often causes patterned hair loss, with some scalp areas more resistant to hair loss than others.

The document concludes that more research is needed to understand excessive hair growth in women with normal hormone levels and regular ovulation.

Plant steroid hormones show growth, health, and medicinal benefits in various organisms, including potential for treating diseases.

Cinnamomi cortex may help treat prostate enlargement by reducing related proteins.

The document concludes that correct diagnosis and management of PCOS are important, and more research is needed on its risks and treatments.

Cyproterone acetate treatment is safe and causes mild feminization, which increases with added estrogen.

Certain HSD3B1 gene types are linked to worse prostate cancer outcomes and affect treatment response and other health conditions.

Researchers found genetic mutations causing hypohidrotic ectodermal dysplasia in 88% of studied patients and identified new mutations and genetic variations affecting the disease.

NcoA4 may have roles beyond helping control gene activity, possibly affecting cell behavior and stability.

17α-estradiol is a safe estrogen that might protect the brain and doesn't cause feminization, needing more research for treating brain diseases.

The study found that women with hyperandrogenic PCOS have higher levels of AKT1 and AKT2 proteins in their cells, which may lead to cell dysfunction.

Men with male pattern hair loss have different levels of certain hormones compared to men without hair loss.

The document concludes that various drugs can manage symptoms and metabolic issues in women with PCOS.

Male pattern baldness involves hormone-related hair thinning, shorter hair, and inflammation.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.

Measuring the distance from the anus to the clitoris may moderately help diagnose polycystic ovary syndrome, especially in certain cases.

P-cadherin is important for hair growth and health, and its problems can cause hair and skin disorders.

ERβ has potential in treating prostate cancer and neurodegenerative diseases, but human studies are needed before clinical use.

Women with nonclassic congenital adrenal hyperplasia experience more sexual dysfunction and distress.